December 23, 2024 10:24 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
11 killed in Jaipur gas tanker crash, several injured critically | Bengaluru techie suicide: Atul Subhash's mother approaches Supreme Court seeking custody of grandson | Narendra Modi, King Charles III discuss climate action and sustainability during telephonic conversation | Modi govt's 'One Nation, One Election' bills sent to JPC | BJP is desperate: Priyanka Gandhi Vadra on FIR against Rahul Gandhi over parliament scuffle | US govt backs India's request to extradite 26/11 accused Tahawwur Rana, asks Supreme Court to dismiss his plea | Daal mein kuch kaala hain ya sab kuchh kaala hain? SC questions authenticity of scanned OMRs in Bengal recruitment scam case | BJP is creating chaos to distract attention from Ambedkar row: Rahul Gandhi on Parliament tussle | Assault on me and Rahul Gandhi: Congress chief Kharge's charge over parliament chaos | PM Modi dials BJP MPs hospitalised with injuries over parliament showdown

Bangladesh to receive 100,000 doses of Pfizer next month

Apr 27, 2021, at 12:02 am

As Bangladesh struggles to procure vaccines from India, officials informed the country would receive around 100,000 doses of Pfizer next month from the WHO’s Covax facility.

Pfizer-BioNTech apply for US authorization to use Its vaccine in adolescents : Statement

Apr 10, 2021, at 04:08 pm

Washington/Sputnik: Pfizer and BioNTech said in a statement that they have applied to expand emergency use authorization of their vaccine for usage in adolescents between 12 and 15 years old.

Pfizer- BioNTech seek permission for emergency use of Covid-19 vaccine in adolescents in US

Apr 10, 2021, at 06:11 am

Washington/IBNS: US drug major Pfizer Inc and its German partner BioNTech SE have sought the permission for emergency use of their vaccine in adolescents aged 12 to 15, according to a Reuters report.

BioNTech-Pfizer claims COVID-19 vaccine 100 percent effective on 12-15 years olds

Mar 31, 2021, at 10:52 pm

New York: Pfizer Inc. and BioNTech SE on Wednesday announced that, in a Phase 3 trial in adolescents 12 to 15 years of age with or without prior evidence of SARS-CoV-2 infection, the Pfizer-BioNTech COVID-19 vaccine BNT162b2 demonstrated 100% efficacy and robust antibody responses, exceeding those recorded earlier in vaccinated participants aged 16 to 25 years old, and was well tolerated.

US study says Pfizer, Moderna COVID-19 vaccines effective even after first shot in real-world use

Mar 30, 2021, at 03:44 pm

Washignton: A new CDC study provides strong evidence that mRNA COVID-19 vaccines are highly effective in preventing SARS-CoV-2 infections in real-world conditions among health care personnel, first responders, and other essential workers.

Japan receives second batch of Pfizer shots against COVID-19: Reports

Feb 21, 2021, at 03:22 pm

Tokyo/Sputnik: The second batch of Pfizer coronavirus vaccine doses has been delivered to Japan, the country’s media report.

Pfizer withdraws emergency use request for its Covid-19 vaccine in India

Feb 05, 2021, at 09:33 pm

New Delhi/IBNS: Drug manufacturer Pfizer has withdrawn application for emergency use of its coronavirus vaccine in India to provide additional information sought by the drug regulator of India.

Benyamin Netanyahu receives 2nd dose of Covid-19 vaccine, vows all Israelis to be inoculated by March

Jan 10, 2021, at 02:45 pm

Tel Aviv/Sputnik: Israeli Prime Minister Benyamin Netanyahu on Saturday received his second dose of the Pfizer/BioNTech coronavirus vaccine live on national television.

Pfizer-funded research claims vaccine might be effective against new Coronavirus strains

Jan 08, 2021, at 08:50 pm

Moscow/Sputnik: The efficacy of the Pfizer coronavirus vaccine (official name BNT162b2) might sustain against the newly-detected mutant strains from the United Kingdom and South Africa, a group of US scientists said in a research paper.

Govt's expert panel clears Oxford COVID-19 vaccine for India

Jan 02, 2021, at 03:56 am

New Delhi/IBNS: A government-appointed panel of experts on Friday cleared the Oxford COVID-19 vaccine manufactured by the Serum Institute of India, which will be sent for approval to the regulator Drugs Controller General of India (DCGI).

Govt's expert panel to meet over Covid-19 vaccine approval today

Jan 01, 2021, at 04:30 pm

New Delhi/IBNS: An expert panel, appointed by the central government, will on Friday meet over the approval for an emergency use of three Covid-19 vaccines, including an indigenous one.

Allergic reaction to Pfizer Coronavirus vaccine reported in Greece

Dec 29, 2020, at 03:27 pm

Athens/Sputnik: One case of an allergic reaction to the Pfizer/BioNTech coronavirus vaccine has been reported in Greece, Primary Health Care Secretary General Marios Themistokleous said at a Health Ministry briefing.

Oxford vaccine to be 95 pc effective at par with Moderna and Pfizer, says maker AstraZeneca

Dec 28, 2020, at 01:19 am

New Delhi/IBNS: Oxford coronavirus vaccine manufacturer AstraZeneca has claimed that it will shield 95 per cent of the patients and be as effective as Moderna and Pfizer alternatives though the British-Swedish pharma giant is yet to release the data confirming the claim, said media reports.

'I didn't feel a thing', says US Vice President Mike Pence after receiving Covid-19 vaccine shot

Dec 19, 2020, at 03:38 am

Washington/IBNS:  United States Vice President Mike Pence on Friday received a Covid-19 vaccine shot in a live television appearance in an attempt to boost public confidence about its effectiveness.

US FDA authorizes emergency use of Pfizer's COVID-19 vaccine: Reports

Dec 12, 2020, at 02:30 pm

Washington/Sputnik: The US Food and Drug Administration (FDA) has issued an authorization for the emergency use of Pfizer’s vaccine against the coronavirus, The New York Times newspaper reported citing its sources.

Bahrain approves Pfizer-BioNTech vaccine against Covid-19

Dec 05, 2020, at 04:26 pm

Manama/IBNS: Bahrain became the second country in the world to approve an emergency use of the vaccine against Covid-19 developed by US pharmaceutical giant Pfizer and its German partner BioNTech.

Pfizer to only get half of COVID-19 vaccines out this year due to logistics: Reports

Dec 04, 2020, at 02:45 pm

Washington/Sputnik: US drug giant Pfizer expects to ship just about half of the COVID-19 vaccines it originally planned for this year because of supply-chain problems, although it still expects to roll out more than a billion doses in 2021, the Wall Street Journal reported.

India's Covid-19 tally crosses 95 lakh with over 35,000 new cases in 24 hours

Dec 03, 2020, at 04:21 pm

New Delhi/IBNS: India's Novel Coronavirus tally on Thursday crossed 95 lakh with the reporting of over 35,000 new infections in the last 24 hours.

UK approves Pfizer-BioNTech vaccine against Covid-19 for roll out

Dec 02, 2020, at 06:37 pm

London/IBNS: The United Kingdom has become the first country to approve the Pfizer-BioNTech vaccine against Covid-19 for widespread use, media reports said.

Pfizer COVID-19 vaccine emerges 95 percent effective in final analysis

Nov 18, 2020, at 11:42 pm

Washington:  Pharmaceutical major Pfizer on Wednesday confirmed that its COVID-19 vaccine candidate is 95 percent effective in the final analysis of the Phase 3 trial.

Pfizer launches pilot COVID-19 vaccine distribution preparedness program in 4 US states

Nov 17, 2020, at 10:14 pm

Moscow/Sputnik: US pharmaceutical company Pfizer announced in a press release on Tuesday it was launching a pilot program that aims to inform the delivery and distribution of its coronavirus vaccine in the US states of Rhode Island, Texas, New Mexico and Tennessee.

Spain expects to receive 20Mln Pfizer vaccine doses in early 2021: Spanish Health Minister

Nov 10, 2020, at 11:52 pm

Moscow/UNI: The Spanish government expects to receive 20 million doses of Pfizer vaccine by early 2021, said Spanish Health Minister Salvador Illa said on Tuesday.

COVID-19 vaccine offers 90 percent protection: Pfizer

Nov 09, 2020, at 11:20 pm

Washington: A COVID-19 vaccine, which is jointly developed by Pfizer and BioNTech, has shown 90 percent effectiveness in preventing Covid-19 infections during the ongoing Phase 3 trials, the companies said on Monday.

Pfizer stops sale of Corex cough syrup in India after ban

Mar 14, 2016, at 08:06 pm

Mumbai, Mar 14 (IBNS) Pharmaceutical major Pfizer has stopped manufacture and sale of popular cough syrup Corex with immediate effect after a ban by the Government.